Soteropoulos Paula
Dianthus Therapeutics, Inc. · Director
Soteropoulos Paula is listed in filings as Director at Dianthus Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 22, 2026, including sale activity. Recent filings connect the profile to Dianthus Therapeutics, Inc. (DNTH), Rallybio Corporation (RLYB), and uniQure N.V. (QURE). The current snapshot covers public activity from Jun 17, 2024 to May 22, 2026. Reported amounts are shown as $545.8K to $5.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $48k599 shares | SellMar 31, 2026 | $80.11 | $95.35 | |
| $2M27.6k shares | SellMar 24, 2026 | $78.05 | $95.35 | |
| $11k2.2k shares | SellJun 13, 2024 | $5.14 | $40.09 |